High performance and low complication rates of a subcutaneous vascular access device: The LifeSite® Hemodialysis Access System

Dialysis and Transplantation

Volumn 31, Issue 11, 2002, Pages 799-806

  Lamarche, Maximo B ^a   Zeik, Juan C ^a   Clark, Roderick V ^a  

^a Cancer Center of Acadiana   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FIBRINOLYTIC AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BLOOD CLOT LYSIS; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DEVICE INFECTION; FEMALE; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN MANIFESTATION; TREATMENT OUTCOME; VASCULAR ACCESS;

EID: 0036842779     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines for vascular access: Update 2000. Am J Kidney Dis 2001; 37:S137-S181.
2. Mandolfo S, Galli F, Costa S, Ravani P, Gaggia P, Imbasciati E. Factors influencing permanent catheter performance. J Vasc Access 2001; 2:106-109.
3. Schwab SJ, Weiss MA, Fushton F, Ross JP, Jackson J, Kapoian T, Yegge J, Rosenblatt M, Caridi JG, Resse WJ, Soundararajan R, Work J, Ross J, Stainken B, Pedan A, Moran JE. Multicenter clinical trial results with the LifeSite® Hemodialysis Access System. Kidney Int 2002; 62:1026-1033.
4. Moran JE. Subcutaneous vascular access devices. Semin Dial 2001; 14:452-457.
5. Wofford S. Care and maintenance of hemodialysis catheters and subcutaneous vascular access devices: A nurse's perspective. Nephrol News Issues 2002; 16:27-31.
6. United States Renal Data System, USRDS 2001 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Minneapolis, MN: National Institutes of Health USRDS Coordinating Center, Minneapolis Medical Research Foundation, 2001.
7. Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL. Longitudinal comparison of dialysis access methods: Risk factors for failure. J Vasc Surg 1997; 26:1009-1019.
8. Glickman MH, Stokes GK, Ross JR, Schuman ED, Sternbergh WC, et al. Multicenter evaluation of a polyurethaneurea vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications. J Vasc Surg 2001; 34:465-473.
9. Schwab SJ, Harrington JT, Singh A, Roher R, Shohaib SA, Perrone RD, Meyer K, Beasley D. Vascular access for hemodialysis. Kidney Int 1999; 55:2078-2090.
10. Ross J. Bridging to a high-flow upper arm native fistula for hemodialysis with the LifeSite® Hemodialysis Access System. J Vasc Access 2001; 2:139-144.
11. Haynes BJ, Quarles AW, Vavrinchik J, White J, Pedan A. The LifeSite® Hemodialysis Access System: Implications for the nephrology nurse. Nephrol Nurs J 2002; 29:27-33,72.
12. Beathard GA, Posen GA. Initial clinical results with the LifeSite® Hemodialysis Access System. Kidney Int 2000; 58:2221-2227.
13. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int 2001; 60:1-13.
14. Saad TF. Central venous dialysis catheters: Catheter-associated infection. Semin Dial 2001; 14:446-451.